Home›Companies›Biotech & Pharma›TearClear

TearClear Corp.

Updated Oct 27, 2026·Latest SEC filing Jul 13, 2023·Suggest an edit

About TearClear

TearClear is a private company based in Princeton, New Jersey. It has reported $52,431,913 raised in six offerings on Form D since May 2017.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jun 29, 2023Jul 13, 2023$11,764,262of $15.9M target70$168KEquityRule 506(b)Form D ↗
Apr 18, 2022Apr 27, 2022amended Aug 16, 2022$5,900,000of $10.0M target43$137KDebtRule 506(b)Form D/A ↗1 earlier filing
Apr 15, 2020Apr 28, 2020amended Aug 19, 2020$22,346,503of $25.9M target51$438KEquityRule 506(b)Form D/A ↗2 earlier filings
Jan 31, 2020Feb 14, 2020$2,790,000of $3.0M target32$87,188DebtRule 506(b)Form D ↗
Feb 1, 2019Feb 14, 2019$4,999,999of $5.0M target22$227KEquityRule 506(b)Form D ↗
May 11, 2017May 19, 2017amended May 31, 2017$4,631,149of $4.6M target11$421KEquityRule 506(b)Form D/A ↗1 earlier filing
Total, six offerings$52,431,913

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on TearClear's Form D filed Jul 13, 2023.

RH
TS
Tyler Stowater
Director
Also a director at Sydnexis.
SR
SV
Srini Venkatesh
Executive officer
RH
Richard Harrison
Chief Financial Officer
WL
William Link
Director
JW
Jeffry Weinhuff
Director
Also a director at Sydnexis.

Earlier filings also listed Robert Bailey (director, last listed Aug 2022), Kevin Hershfield (executive officer, last listed Aug 2022), Steve Pazol (director, last listed Aug 2020) and Robert Dempsey (chief executive officer and director, last listed Aug 2020).

Sources

  1. SECTearClear Corp. Form D, filed Apr 27, 2022
  2. SECTearClear Corp. Form D/A, filed Jul 23, 2020
  3. SECTearClear Corp. Form D, filed Apr 28, 2020
  4. SECTearClear Corp. Form D, filed May 19, 2017
  5. SECTearClear Corp. filing history